Deutsche Bank Ag\ Eton Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$5.71 - $8.85 $67,789 - $105,067	-11,872 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$6.93 - $10.07 $8,468 - $12,305	-1,222 Reduced 9.33%	11,872 $86,000
Q4 2020 Feb 16, 2021	BUY	$6.65 - $8.83 $29,785 - $39,549	4,479 Added 51.99%	13,094 $106,000
Q3 2020 Nov 12, 2020	BUY	$4.96 - $9.06 $9,071 - $16,570	1,829 Added 26.95%	8,615 $68,000
Q2 2020 Aug 13, 2020	BUY	$3.5 - $6.09 $23,751 - $41,326	6,786 New	6,786 $37,000
Q2 2019 Aug 14, 2019	SELL	$7.1 - $8.39 $11,509 - $13,600	-1,621 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$5.72 - $8.0 $7,556 - $10,568	1,321 Added 440.33%	1,621 $12,000
Q4 2018 Feb 14, 2019	BUY	$5.79 - $6.68 $1,737 - $2,004	300 New	300 $1,000

9.44M

261K

500

Ticker ETON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,297,000
Market Cap $274M
Description
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.